Method for identifying individual at risk for irreversible neurodamages, comprising steps of determining quantatively concentration of pepsinogen I(PGI) and vitamin B12
A technology for nerve damage, vitamins, applied in the field of combined diagnosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0018] 1. Detection of pepsinogen I (PGI)
[0019] Detection of PGI in serum samples can be performed as described in WO96 / 15456, which publication is incorporated herein by reference.
[0020] The above-mentioned method preferably comprises the step of detecting pepsinogen I using a poly or monoclonal antibody against pepsinogen I in an immunological method. Preferably the reaction is carried out on a suitable support, such as a plastic, glass or cellulose support, eg a microtiter plate. Immunological methods can be performed in a known manner, such as using absorbance, luminescence or fluorescence techniques to detect the concentration of pepsinogen I in the above-mentioned samples.
[0021] In this case, the method-specific threshold for serum PGI is chosen according to the specificity and sensitivity of the assay used to detect the analyte concentration, and is well known to those skilled in the art, see, for example, William J Marshall, Clinical Chemistry, Third Edition...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More